Oregon
(State
or jurisdiction of
incorporation
or organization) |
93-0822509
(I.R.S.
Employer
Identification
No.) |
3 | ||
4 | ||
5 | ||
6 | ||
10 | ||
16 | ||
17 |
19 |
ITEM | 1. FINANCIAL STATEMENTS |
December
31, |
September
30, |
|||||||||
2004 |
2004 |
|||||||||
(in
thousands) |
||||||||||
Assets |
||||||||||
Current
assets: |
||||||||||
Cash
and cash equivalents |
$ |
11,325 |
$ |
8,817 |
||||||
Trade
accounts receivable, net |
6,704
|
9,336
|
||||||||
Inventories: |
||||||||||
Raw
materials |
6,860
|
6,460
|
||||||||
Work-in-process
and sub-assemblies |
5,569
|
4,749
|
||||||||
Finished
goods |
2,441
|
2,424
|
||||||||
Total
inventories |
14,870
|
13,633
|
||||||||
Other
current assets |
3,650
|
3,216
|
||||||||
Total
current assets |
36,549
|
35,002
|
||||||||
Property,
plant and equipment, net |
4,842
|
5,046
|
||||||||
Deferred
income taxes |
-
|
6
|
||||||||
Investment
in joint venture |
1,745
|
1,914
|
||||||||
Goodwill,
net |
2,524
|
2,524
|
||||||||
Intangibles
and other assets, net |
7,691
|
8,022
|
||||||||
Total |
$ |
53,351 |
$ |
52,514 |
||||||
Liabilities
and Shareholders' Equity |
||||||||||
Current
liabilities: |
||||||||||
Accounts
payable |
$ |
1,964 |
$ |
1,599 |
||||||
Accrued
payroll liabilities and commissions |
3,145
|
3,781
|
||||||||
Accrued
customer support and warranty costs |
1,159
|
1,283
|
||||||||
Other
accrued liabilities |
2,163
|
2,007
|
||||||||
Customers'
deposits |
3,667
|
2,536
|
||||||||
Current
portion of long-term debt and capital lease obligations |
1,199
|
1,210
|
||||||||
Current
portion of mandatorily redeemable preferred stock |
1,246
|
1,279
|
||||||||
Current
portion of warrants |
313
|
316
|
||||||||
Total
current liabilities |
14,856
|
14,011
|
||||||||
Long-term
debt and capital lease obligations |
2,106
|
2,323
|
||||||||
Deferred
income taxes |
328
|
136
|
||||||||
Total
shareholders' equity |
36,061
|
36,044
|
||||||||
Total |
$ |
53,351 |
$ |
52,514 |
||||||
See
notes to condensed unaudited consolidated financial
statements. |
2004 |
2003 |
|||||||||
(in thousands, except per share data) | ||||||||||
Net
sales |
$ |
14,571 |
$ |
18,743 |
||||||
Cost
of sales |
9,266
|
11,687
|
||||||||
Gross
profit |
5,305
|
7,056
|
||||||||
Operating
expenses: |
||||||||||
Sales
and marketing |
3,031
|
3,321
|
||||||||
Research
and development |
1,340
|
1,137
|
||||||||
General
and administrative |
1,766
|
1,571
|
||||||||
Amortization
of intangibles |
331
|
331
|
||||||||
Total
operating expenses |
6,468
|
6,360
|
||||||||
Gain
on sale of assets |
5
|
-
|
||||||||
Earnings
(loss) from operations |
(1,158 |
) |
696
|
|||||||
Other
income |
427
|
74
|
||||||||
Earnings
(loss) before income taxes |
(731 |
) |
770
|
|||||||
Income
tax (benefit) expense |
(289 |
) |
265
|
|||||||
Net
earnings (loss) |
(442 |
) |
505
|
|||||||
Assumed
dividends on mandatorily redeemable preferred stock |
-
|
(10 |
) | |||||||
Net
earnings (loss) available to common shareholders |
$ |
(442 |
) |
$ |
495 |
|||||
Earnings
(loss) per share |
||||||||||
-
basic |
$ |
(0.09 |
) |
$ |
0.10 |
|||||
-
diluted |
$ |
(0.09 |
) |
$ |
0.10 |
|||||
Shares
used in per share calculations - basic |
4,996
|
4,816
|
||||||||
Shares
used in per share calculations - diluted |
4,996
|
5,188
|
||||||||
See
notes to condensed unaudited consolidated financial
statements. |
2004 |
2003 |
|||||||||
(in
thousands) |
||||||||||
Net
cash provided by operating activities |
$ |
2,722 |
$ |
718 |
||||||
Cash
flows from investing activities: |
||||||||||
Additions
to property, plant and equipment |
(102 |
) |
(153 |
) | ||||||
Net
cash used in investing activities |
(102 |
) |
(153 |
) | ||||||
Cash
flows from financing activities: |
||||||||||
Repayment
of long-term debt |
(292 |
) |
(243 |
) | ||||||
Redemption
of preferred stock |
(32 |
) |
(39 |
) | ||||||
Redemption
of warrants |
(3 |
) |
(7 |
) | ||||||
Proceeds
from issuance of common stock |
149
|
617
|
||||||||
Net
cash provided by (used in) financing activities |
(178 |
) |
328
|
|||||||
Effect
of exchange rates on cash |
66
|
63
|
||||||||
Net
increase in cash and cash equivalents |
2,508
|
956
|
||||||||
Cash
and cash equivalents, beginning of the period |
8,817
|
6,442
|
||||||||
Cash
and cash equivalents, end of the period |
$ |
11,325 |
$ |
7,398 |
||||||
Supplemental
information: |
||||||||||
Cash
paid during the period for interest |
$ |
48 |
$ |
54 |
||||||
Cash
paid (refunded) during the period for income taxes |
$ |
(131 |
) |
$ |
48 |
|||||
See
notes to condensed unaudited consolidated financial
statements. |
1. | Condensed unaudited consolidated financial statements |
2. | Stock Compensation |
Three
months ended December 31, | |||||||
2004 |
2003 |
||||||
Net
earnings (loss), as reported |
$ |
(442 |
) |
$ |
505 |
||
Deduct:
Total stock-based employee compensation expense determined under fair
value based method for all awards, net of related tax
effects |
(74 |
) |
$ |
(136 |
) | ||
Pro
forma net earnings (loss) |
$ |
(516 |
) |
$ |
369 |
||
Earnings
(loss) per share: |
|||||||
Basic
- as reported |
$ |
(0.09 |
) |
$ |
0.10 |
||
Basic
- pro forma |
$ |
(0.10 |
) |
$ |
0.08 |
||
Diluted
- as reported |
$ |
(0.09 |
) |
$ |
0.10 |
||
Diluted
- pro forma |
$ |
(0.10 |
) |
$ |
0.07 |
For
the three months ended December 31, 2004 | ||||||||||
Earnings |
Shares |
Per-Share
Amount |
||||||||
Net
loss from continuing operations |
$ |
(442 |
) |
|||||||
Less:
Assumed dividends on mandatorily redeemable preferred
stock |
-
|
|||||||||
Basic
EPS: |
||||||||||
Net
loss available to common shareholders |
(442 |
) |
4,996 |
$ |
(0.09 |
) | ||||
Effect
of dilutive securities: |
||||||||||
Common
stock options |
- |
|||||||||
Mandatorily
redeemable preferred stock |
- |
- |
||||||||
Diluted
EPS: |
||||||||||
Loss
available to common shareholders plus assumed conversions |
$ |
(442 |
) |
4,996 |
$ |
(0.09 |
) |
For
the three months ended December 31, 2003 |
||||||||||
Earnings |
Shares |
Per-Share
Amount |
||||||||
Net
earnings from continuing operations |
$ |
505 |
||||||||
Less:
Assumed dividends on mandatorily redeemable preferred
stock |
(10 |
) |
||||||||
Basic
EPS: |
||||||||||
Net
earnings available to common shareholders |
495
|
4,816 |
$ |
0.10 |
||||||
Effect
of dilutive securities: |
||||||||||
Common
stock options |
- |
271 |
||||||||
Mandatorily
redeemable preferred stock |
10
|
101 |
||||||||
Diluted
EPS: |
||||||||||
Income
available to common shareholders plus assumed conversions |
$ |
505 |
5,188 |
$ |
0.10 |
4. | Income taxes |
5. | Comprehensive income |
Three
months ended |
|||||||
December
31, 2004 |
December
31, 2003 |
||||||
Components
of comprehensive income (loss): |
|||||||
Net
earnings (loss) |
$ |
(442 |
) |
$ |
505 |
||
Other
comprehensive income - |
|||||||
foreign
currency translation adjustment, net of tax |
280
|
257
|
|||||
Total
comprehensive income (loss) |
$ |
(162 |
) |
$ |
762 |
6. | Contractual guarantees and indemnities |
Three
months ended | |||||||
December
31, 2004 |
December
31, 2003 |
||||||
Beginning
balance |
$ |
889 |
$ |
837 |
|||
Warranty
costs incurred |
(443 |
) |
(523 |
) | |||
Warranty
expense accrued |
407
|
487
|
|||||
Translation
adjustments |
21
|
17
|
|||||
Ending
balance |
$ |
874 |
$ |
818 |
7. | Future accounting changes |
· | adverse economic conditions, particularly in the food processing industry, may adversely affect the Company's revenues; |
· | competition and advances in technology may adversely affect sales and prices; |
· | the Company's new products may not compete successfully in either existing or new markets; |
· | the limited availability and possible cost fluctuations of materials used in the Company's products could adversely affect the Company's gross profits; |
· | the Company's inability to protect its intellectual property may adversely affect the Company's competitive advantage; |
· | intellectual property-related litigation expenses and other costs resulting from infringement claims asserted against the Company or its customers by third parties may adversely affect the Company’s results of operations and its customer relations; and |
· | the other factors discussed in Exhibit 99.1 to the Company’s Annual Report on Form 10-K filed with the SEC on December 17, 2004, which exhibit is hereby incorporated by reference. |
· | Revenue recognition |
· | Allowances for doubtful accounts |
· | Valuation of inventories |
· | Long-lived assets |
· | Allowances for warranties |
· | Accounting for income taxes |
Payments
due by period (in Thousands) |
||||||||||||||||
Contractual
Obligations |
Total |
Less
than 1 year |
1
- 3 years |
4
- 5 years |
After
5 years |
|||||||||||
Long-term
debt * |
$ |
2,940 |
$ |
966 |
$ |
1,634 |
$ |
136 |
$ |
204 |
||||||
Capital
lease obligations |
365 |
233 |
132 |
- |
- |
|||||||||||
Operating
leases |
10,411 |
1,494 |
2,810 |
1,874 |
4,233 |
|||||||||||
Warrant
redemption obligations |
313 |
313 |
- |
- |
- |
|||||||||||
Series
B redemption obligations |
1,246 |
1,246 |
- |
- |
- |
|||||||||||
Total
contractual cash obligations |
$ |
15,275 |
$ |
4,252 |
$ |
4,576 |
$ |
2,010 |
$ |
4,437 |
· | Translation adjustments of $280,000, net of income tax, were recognized as a component of comprehensive income (loss) as a result of converting the Euro denominated balance sheet of Key Technology B.V. into U.S. dollars, and to a lesser extent, the Australian dollar balance sheet of Key Technology Australia Pty. Ltd. |
· | Foreign exchange gains of $79,000 were recognized in the other income and expense section of the consolidated statement of operations as a result of conversion of Euro and other foreign currency denominated receivables and cash carried on the balance sheet of the U.S. operations, as well as the result of the conversion of other non-functional currency receivables, payables and cash carried on the balance sheet of the European operations. |
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Mandatorily
Redeemable Series B Convertible Preferred Stock (1) |
|||||||||||||
Period |
Total
Number of Shares Purchased |
Average
Price Paid per Share |
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs |
Maximum
Number of Shares that May Yet Be Purchased Under the Plans or
Programs |
|||||||||
October
1 - 31, 2004 |
0 |
- |
- |
||||||||||
November
1 - 30, 2004 |
1,500 |
$ |
10 |
- |
|||||||||
December
1 - 31, 2004 |
1,750 |
$ |
10 |
- |
|||||||||
Total |
3,250 |
124,629 |
Warrants
(2) |
|||||||||||||
Period |
Total
Number of Warrants Purchased |
Average
Price Paid per Warrant |
Total
Number of Warrants Purchased as Part of Publicly Announced Plans or
Programs |
Maximum
Number of Warrants that May Yet Be Purchased Under the Plans or
Programs |
|||||||||
October
1-31, 2004 |
0 |
- |
- |
||||||||||
November
1-30, 2004 |
87 |
$ |
10 |
- |
|||||||||
December
1-31, 2004 |
208 |
$ |
10 |
- |
|||||||||
Total |
295 |
31,341 |
(1) | The Company issued 1,340,366 shares of Series B convertible preferred stock (“Series B”) at a price of $8.60 per share in conjunction with the acquisition of Advanced Machine Vision Corporation on July 12, 2000. Each share of Series B, par value of $0.01 per share, may be converted into 2/3 of a share of common stock. The Series B is convertible at the option of the holder at any time, unless previously redeemed, or by the Company upon a merger, consolidation, share exchange or sale of substantially all of its assets. The holders of Series B may require the Company to repurchase any or all of their shares at any time after July 12, 2002 at the redemption price of $10.00. If not converted to common stock or redeemed at the option of the Series B holder after July 12, 2002, the Company must redeem the Series B for $10.00 per share on July 12, 2005. The redemption date may be accelerated if the average closing price of Key Technology common stock, as listed on the Nasdaq National Market, is $15.00 or more for thirty consecutive trading days. |
(2) | The Company issued 365,222 warrants at a fair market value of $10.00 per warrant in conjunction with the issuance of the Series B. Each warrant entitles its holder to purchase at any time for a period of five years from July 12, 2000 one share of common stock at $15.00 per share, subject to certain adjustments. The warrants permit the holder to engage in a net exercise of the warrants if the fair market value of one share of common stock is greater than $15.00 per share on the date of exercise. Prior to the expiration date of the warrant, the holder may require the Company to redeem the warrant for cash at a price equal to $10.00 for each whole share of common stock that may be purchased under the warrant. |
(a) | Exhibits |
31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
SIGNATURES | |
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized. | |
KEY
TECHNOLOGY, INC. | |
(Registrant) | |
Date:
February 9, 2005 |
By
/s/
Kirk W. Morton |
President
and Chief Executive Officer | |
(Principal
Executive Officer) | |
Date:
February 9, 2005 |
By
/s/
Phyllis C. Best |
Chief
Financial Officer | |
(Principal
Financial and Accounting Officer) | |
31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2 | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |